Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Blood red petri-dish in the hand of a researcher with bacterial colonies grown on the plate.

Prof Paresh Vyas and his team are investigating haematopoietic stem cells (HSCs) and clonal haematopoiesis (CH), associated with cardiovascular disease and blood cancers. They have been collecting bone marrow samples from otherwise well patients having hip-replacement operations to further understand the mechanisms involved to help develop targeted therapies.

More recently the team have also been studying patients with COVID-19, to understand if CH has an impact on the clinical course of COVID-19. Find out more about this research on the Cancer Research UK Oxford Centre's website.

Similar stories

Project funding for personalised childhood cancer treatments

Funding from the Azaylia Foundation will support the Scientific Advances for Infant Leukaemia (SAIL) programme.

MRC National Mouse Genetics Network Research Clusters Announced

Claus Nerlov and Steve Twigg from the MRC WIMM join the new national network for disease modelling.

Patient priorities guide Oxford Myeloma research

Medical staff in Oxford are partnering closely with Myeloma patients to help set priorities for future research.

From ‘Ew, gross!’ to ‘Wow!’: Scientists bring immunology to the classroom

For British Science Week, members of the MRC WIMM visited a local Oxfordshire primary school for an interactive science day – one of the first of its kind since the start of the pandemic.

Spin-out company Alethiomics launches

The enterprise will focus on developing targeted therapies for a specific family of blood cancers.